Loading clinical trials...
Loading clinical trials...
Sleeve gastrectomy (SG) continues to be one of the most popular bariatric procedures all over the world. It has been established that obesity is a predisposing factor for several comorbidities, including life-threatening conditions. Many studies have discussed the impact of sleeve gastrectomy on TSH level. But, since most obese patients have some sort of depression, we will try to study the impact of sleeve gastrectomy, depression and hypothyroidism on each other.
Age
18 - 60 years
Sex
ALL
Healthy Volunteers
No
Faculty of Medicine
Zagazig, Sharqia Province, Egypt
Zagazig University Hospitals
Zagazig, Egypt
Start Date
March 1, 2025
Primary Completion Date
March 1, 2026
Completion Date
March 1, 2026
Last Updated
August 14, 2025
24
ESTIMATED participants
laparoscopic sleeve gastrectomy
PROCEDURE
Lead Sponsor
Zagazig University
NCT07049861
NCT06858683
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06856291